2025年全球PCR市场将超过70亿美元

据市场研究和咨询公司Coherent Market Insights的最新报告，美国全球聚合酶链式反应市场（PCR）2017年价值37亿美元，预计到2025年，预测期内（2017-2025）的复合年增长率将达8.8％，超过74亿美元。PCR实验室技术在各个领域的广泛应用，传染病和慢性疾病的流行率和发病率的增加，以及对快速、廉价的高定量检测PCR系统的需求预计将成为关键的增长驱动因素 PCR市场在预测期间。

基于产品类型，由于PCR仪器中运行样品并扩增DNA靶序列的需要，因此试剂和耗材占PCR市场的最大份额。

基于终端用户，由于高级实验室测试和研究服务对PCR系统的需求日益增加，学术和研究实验室占据了最大的市场份额。

在传染病的临床诊断，核酸扩增，亲子鉴定，DNA指纹鉴定，传染病检测和诊断，质量控制和个性化医疗方面，PCR的使用正在增加。然而，由于研发进展导致产生各种替代性核酸扩增方法，例如循环药物等温扩增，基于核酸序列的扩增，链置换扩增和多重置换扩增。与PCR相比，这些方法在核酸扩增中提供了更好的适用性和灵敏度，PCR具有污染，对某些类别的污染物和抑制剂的敏感性以及热循环的要求等限制。这些替代核酸扩增方法可能会阻碍PCR市场在预测期间的增长。

PCR市场的主要参与者提出了不使用PCR扩增技术的核酸检测方法。他们还推出了先进的新型PCR仪器和耗材，可快速简便地扩增核酸。此外，这些主要参与者已经进入了许多合作项目，以扩大其地理覆盖范围并增加病人的覆盖面。因此，各主要企业采用的重要内生和非内生增长战略正在推动PCR市场的增长。从地理位置上看，高利润市场特别是亚太地区，拉丁美洲，中东和非洲地区对更先进的PCR技术的需求不断增加。
 

Global PCR Market

Global PCR Market to Surpass USD 7 Billion by 2025

The global polymerase chain reaction market (PCR) was valued at USD 3.7 billion in 2017 and is projected to grow at a CAGR of 8.8% over the forecast period (2017 – 2025) to surpass USD 7.4 billion by 2025. The extensive applications of the PCR laboratory technique in various fields, rising prevalence and incidence of infectious and chronic diseases, and growing need to develop advanced PCR systems for the rapid and inexpensive quantitative detection of target samples are expected to be the key growth drivers of the PCR market during the forecast period.

These are the latest findings of Coherent Market Insights (Seattle, WA, USA), a market research and consulting firm.

Based on product type, reagents and consumables hold the largest share of the PCR market due to the need to run the sample and amplify the target DNA sequence in PCR instruments. Based on end-user, academic and research laboratories account for the largest market share, on account of the increasing need for PCR systems in advanced laboratory testing and research services.

The use of PCR is increasing in the clinical diagnosis of infectious disease, nucleic acid amplification, paternity testing, DNA fingerprinting, detection and diagnosis of infectious disease, quality control, and personalized medicine. However, R&D advancements are resulting in the creation of various alternative nucleic acid amplification methods, such as loop medicated isothermal amplification, nucleic acid sequence based amplification, strand displacement amplification, and multiple displacement amplification. These methods offer better applicability and sensitivity in nucleic acid amplification, as compared to PCR, which has limitations such as contamination, sensitivity to certain classes of contaminants and inhibitors, and requirement of thermal cycling. These alternative nucleic acid amplification methods could hamper the growth of the PCR market during the forecasted period.

The key players in the PCR market offer PCR-free nucleic acid detection methods. They are also launching advanced and novel PCR instruments and consumables, which allow for rapid and easy nucleic acid amplification. Additionally, these key players have entered into a number of collaborations to expand their geographical reach and increase patient reach. Thus, the significant organic and inorganic growth strategies adopted by various key players is driving the growth of the PCR market. Geographically, there is growing demand for continuous technological advancements in PCR from the highly lucrative markets, particularly Asia Pacific, Latin America, the Middle East, and Africa.